Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457968

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457968

Self-Monitoring Blood Glucose Devices Market Size and Share Analysis by Type, Application, End User - Global Industry Demand Forecast to 2030

PUBLISHED:
PAGES: 270 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

In 2023, the worldwide self-monitoring blood glucose devices market accrued revenue of

USD 25.3 billion. It is anticipated to grow at a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030, ultimately reaching USD 48.2 billion by 2030.

This development of the industry is credited to the growing occurrence of diabetes, the rising populace of elderly people, technical improvements, thriving awareness of diabetes care, increasing count of obese populations, and the compensation guidelines for SMBG devices in several nations, such as the U.K., the U.S., Italy, Germany, France, Japan, and Spain, are another significant reason propelling the industry development.

Market Trends

Technical Improvements in SMBG Devices: The worldwide SMBG industry is experiencing a trend of constant technical improvements in SMBG devices. Such innovations comprise the development of new-age instruments that significantly decrease the time taken to test sugar levels compared to traditional lab approaches.

Portability and Convenience: A major trend in the self-monitoring blood glucose devices market is the focus on portability and suitability. Several SMBG devices are made to be compact and simple to carry, offering users better flexibility and convenience in monitoring their blood glucose levels.

Smartphone Integration and Mobile Apps: Another notable trend is the integration of SMBG devices with smartphones and the widespread use of mobile apps. Smartphone apps are playing a crucial role in helping patients manage hyperglycemia by providing education on the condition, promoting healthy lifestyle choices, offering tools for tracking sugar levels, and facilitating medication adherence.

Mobile Sugar Checkers: Companies are increasingly introducing mobile sugar checkers that can be connected to smartphones. These devices allow users to monitor their sugar levels on the go and conveniently access their data through mobile apps, contributing to better management of diabetes and hyperglycemia.

Test Strips Remain the Top-Selling Device Type

In 2023, on the basis of type, the sale of strips had the largest share of 40%. Such strips are manufactured from disposable plastic and saturated with glucose oxides, which aid in checking the sugar level. These lucrative glucose measuring strips can also be utilized for checking the ketone level in the blood.

Increasing Diabetes Frequency with Thriving Elderly and Obese Populations

The worldwide elderly populace is witnessing quick development, as shown by the world population prospects report from the UN.

The share of people elderly 65 years or older is estimated to surge from 10% in 2022 to 16% by 2050, highlighting a substantial demographic shift.

This elderly trend is a major propeller for the development of the self-measuring blood glucose devices industry.

Elderly people are more vulnerable to diabetes in comparison to younger demographics, leading to an augmented need for blood glucose tracking devices between this age group.

North Americans Lead in Diabetes Self-Monitoring and Management

In 2023, the North American region held the largest share, 55%, of the industry.

This dominating regional position can be credited to the increasing occurrence of hyperglycemia and a rising elderly populace, making hyperglycemia a substantial lifestyle disease in North America.

Technical improvements and regular launches of innovative items are contributing to industry development in the continent.

Competition Analysis

For example, in 2022, Dexcom Inc. got FDA clearance for Dexcom G7 for all kinds of hyperglycemic patients ages two years and more in the U.S.

Product Code: 10484

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by application
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Volume, by Application (2017-2030)
  • 6.5. Market Revenue, by Application (2017-2030)
  • 6.6. Market Volume, by End User (2017-2030)
  • 6.7. Market Revenue, by End User (2017-2030)
  • 6.8. Market Volume, by Region (2017-2030)
  • 6.9. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Application (2017-2030)
  • 7.5. Market Revenue, by Application (2017-2030)
  • 7.6. Market Volume, by End User (2017-2030)
  • 7.7. Market Revenue, by End User (2017-2030)
  • 7.8. Market Volume, by Country (2017-2030)
  • 7.9. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Application (2017-2030)
  • 8.5. Market Revenue, by Application (2017-2030)
  • 8.6. Market Volume, by End User (2017-2030)
  • 8.7. Market Revenue, by End User (2017-2030)
  • 8.8. Market Volume, by Country (2017-2030)
  • 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Application (2017-2030)
  • 9.5. Market Revenue, by Application (2017-2030)
  • 9.6. Market Volume, by End User (2017-2030)
  • 9.7. Market Revenue, by End User (2017-2030)
  • 9.8. Market Volume, by Country (2017-2030)
  • 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Application (2017-2030)
  • 10.5. Market Revenue, by Application (2017-2030)
  • 10.6. Market Volume, by End User (2017-2030)
  • 10.7. Market Revenue, by End User (2017-2030)
  • 10.8. Market Volume, by Country (2017-2030)
  • 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Application (2017-2030)
  • 11.5. Market Revenue, by Application (2017-2030)
  • 11.6. Market Volume, by End User (2017-2030)
  • 11.7. Market Revenue, by End User (2017-2030)
  • 11.8. Market Volume, by Country (2017-2030)
  • 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Application (2017-2030)
  • 12.5. Market Revenue, by Application (2017-2030)
  • 12.6. Market Volume, by End User (2017-2030)
  • 12.7. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Application (2017-2030)
  • 13.5. Market Revenue, by Application (2017-2030)
  • 13.6. Market Volume, by End User (2017-2030)
  • 13.7. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Application (2017-2030)
  • 14.5. Market Revenue, by Application (2017-2030)
  • 14.6. Market Volume, by End User (2017-2030)
  • 14.7. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Application (2017-2030)
  • 15.5. Market Revenue, by Application (2017-2030)
  • 15.6. Market Volume, by End User (2017-2030)
  • 15.7. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Application (2017-2030)
  • 16.5. Market Revenue, by Application (2017-2030)
  • 16.6. Market Volume, by End User (2017-2030)
  • 16.7. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Application (2017-2030)
  • 17.5. Market Revenue, by Application (2017-2030)
  • 17.6. Market Volume, by End User (2017-2030)
  • 17.7. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Application (2017-2030)
  • 18.5. Market Revenue, by Application (2017-2030)
  • 18.6. Market Volume, by End User (2017-2030)
  • 18.7. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Application (2017-2030)
  • 19.5. Market Revenue, by Application (2017-2030)
  • 19.6. Market Volume, by End User (2017-2030)
  • 19.7. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Application (2017-2030)
  • 20.5. Market Revenue, by Application (2017-2030)
  • 20.6. Market Volume, by End User (2017-2030)
  • 20.7. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Application (2017-2030)
  • 21.5. Market Revenue, by Application (2017-2030)
  • 21.6. Market Volume, by End User (2017-2030)
  • 21.7. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Application (2017-2030)
  • 22.5. Market Revenue, by Application (2017-2030)
  • 22.6. Market Volume, by End User (2017-2030)
  • 22.7. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Application (2017-2030)
  • 23.5. Market Revenue, by Application (2017-2030)
  • 23.6. Market Volume, by End User (2017-2030)
  • 23.7. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Application (2017-2030)
  • 24.5. Market Revenue, by Application (2017-2030)
  • 24.6. Market Volume, by End User (2017-2030)
  • 24.7. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Application (2017-2030)
  • 25.5. Market Revenue, by Application (2017-2030)
  • 25.6. Market Volume, by End User (2017-2030)
  • 25.7. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Application (2017-2030)
  • 26.5. Market Revenue, by Application (2017-2030)
  • 26.6. Market Volume, by End User (2017-2030)
  • 26.7. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Application (2017-2030)
  • 27.5. Market Revenue, by Application (2017-2030)
  • 27.6. Market Volume, by End User (2017-2030)
  • 27.7. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Application (2017-2030)
  • 28.5. Market Revenue, by Application (2017-2030)
  • 28.6. Market Volume, by End User (2017-2030)
  • 28.7. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Johnson & Johnson Services Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. ARKRAY Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Nova Biomedical
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Bionime Corporation
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Medtronic plc
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. B. Braun Melsungen AG
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Abbott Laboratories
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Bayer AG
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!